
Sign up to save your podcasts
Or


Send us Fan Mail
Join Heather Binning who hosts this week’s special guests Louise Irvine, co-chair of the Clinical Advisory Network on Sex and Gender and Terry Patterson from Thoughtful Therapists.
Louise and Terry explain why there are enormous concerns from sector experts regarding the ethical grounds and outcomes competence of the UK puberty blockers trial called ‘Pathway’, a medical trial which will involve around 220 children under the age of 16.
We hear explanation of the scrutiny stages that UK clinical trials must successfully pass through in order to be granted approval, as well as questioning how this safety net has failed
Useful Links ...
Clinical Advisory Network on Sex and Gender: https://can-sg.org
Open Letter from CAN-SG: https://can-sg.org/2025/12/18/open-letter-to-wes-streeting-on-the-pathways-puberty-blockers-trial/
Thoughtful Therapists: https://www.thoughtfultherapists.org
National Institute for Health and Care Research: https://fundingawards.nihr.ac.uk/award/NIHR167530
Health Research Authority: https://www.hra.nhs.uk/planning-and-improving-research/application-summaries/research-summaries/pathways-trial/
Medicines & Healthcare products Regulatory Agency: https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency
Commission on Human Medicines: https://www.gov.uk/government/organisations/commission-on-human-medicines
If you enjoyed listening to this podcast and would like to hear more, go to womensrights.network/wrn-podcast to listen, download and subscribe to more of our episodes.
And if you’d like to join our conversations, go to womensrights.network/join-wrn
By Women’s Right Network5
55 ratings
Send us Fan Mail
Join Heather Binning who hosts this week’s special guests Louise Irvine, co-chair of the Clinical Advisory Network on Sex and Gender and Terry Patterson from Thoughtful Therapists.
Louise and Terry explain why there are enormous concerns from sector experts regarding the ethical grounds and outcomes competence of the UK puberty blockers trial called ‘Pathway’, a medical trial which will involve around 220 children under the age of 16.
We hear explanation of the scrutiny stages that UK clinical trials must successfully pass through in order to be granted approval, as well as questioning how this safety net has failed
Useful Links ...
Clinical Advisory Network on Sex and Gender: https://can-sg.org
Open Letter from CAN-SG: https://can-sg.org/2025/12/18/open-letter-to-wes-streeting-on-the-pathways-puberty-blockers-trial/
Thoughtful Therapists: https://www.thoughtfultherapists.org
National Institute for Health and Care Research: https://fundingawards.nihr.ac.uk/award/NIHR167530
Health Research Authority: https://www.hra.nhs.uk/planning-and-improving-research/application-summaries/research-summaries/pathways-trial/
Medicines & Healthcare products Regulatory Agency: https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency
Commission on Human Medicines: https://www.gov.uk/government/organisations/commission-on-human-medicines
If you enjoyed listening to this podcast and would like to hear more, go to womensrights.network/wrn-podcast to listen, download and subscribe to more of our episodes.
And if you’d like to join our conversations, go to womensrights.network/join-wrn

188 Listeners

182 Listeners

205 Listeners

52 Listeners

258 Listeners

634 Listeners

66 Listeners

4 Listeners

55 Listeners

2 Listeners

58 Listeners

1 Listeners

0 Listeners